151 related articles for article (PubMed ID: 10715513)
1. Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.
Nishi N; van der Vliet HJ; Koezuka Y; von Blomberg BM; Scheper RJ; Pinedo HM; Giaccone G
Hum Immunol; 2000 Apr; 61(4):357-65. PubMed ID: 10715513
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.
Van Der Vliet HJ; Nishi N; Koezuka Y; Peyrat MA; Von Blomberg BM; Van Den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Immunology; 1999 Dec; 98(4):557-63. PubMed ID: 10594688
[TBL] [Abstract][Full Text] [Related]
3. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
[TBL] [Abstract][Full Text] [Related]
4. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
5. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
[TBL] [Abstract][Full Text] [Related]
7. Expansion of Valpha24(+)Vbeta11(+) NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Flt3-L depends on monocytes.
Okada H; Nagamura-Inoue T; Mori Y; Takahashi TA
Eur J Immunol; 2006 Jan; 36(1):236-44. PubMed ID: 16380959
[TBL] [Abstract][Full Text] [Related]
8. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
10. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.
Ishikawa E; Motohashi S; Ishikawa A; Ito T; Uchida T; Kaneko T; Tanaka Y; Horiguchi S; Okamoto Y; Fujisawa T; Tsuboi K; Taniguchi M; Matsumura A; Nakayama T
Int J Cancer; 2005 Nov; 117(2):265-73. PubMed ID: 15900581
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
14. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
Harada Y; Imataki O; Heike Y; Kawai H; Shimosaka A; Mori S; Kami M; Tanosaki R; Ikarashi Y; Iizuka A; Yoshida M; Wakasugi H; Saito S; Takaue Y; Takei M; Kakizoe T
J Immunother; 2005; 28(4):314-21. PubMed ID: 16000949
[TBL] [Abstract][Full Text] [Related]
15. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources].
Zhai WH; Huang Y; Wang M; Zhou Z; Zhai WJ; Zhang RL; Zhang P; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):633-6. PubMed ID: 19549378
[TBL] [Abstract][Full Text] [Related]
16. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
[TBL] [Abstract][Full Text] [Related]
17. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 1998 May; 12(5):1165-70. PubMed ID: 9538144
[TBL] [Abstract][Full Text] [Related]
19. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]